These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 30020445)

  • 21. Use of statins and adverse outcomes in patients with atrial fibrillation: An analysis from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) general registry pilot phase.
    Proietti M; Laroche C; Nyvad O; Haberka M; Vassilikos VP; Maggioni AP; Boriani G; Lip GYH;
    Int J Cardiol; 2017 Dec; 248():166-172. PubMed ID: 28859841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence and Risk Factors of Stroke or Systemic Embolism in Patients With Atrial Fibrillation and Heart Failure　- The Fushimi AF Registry.
    Iguchi M; Tezuka Y; Ogawa H; Hamatani Y; Takagi D; An Y; Unoki T; Ishii M; Masunaga N; Esato M; Tsuji H; Wada H; Hasegawa K; Abe M; Lip GYH; Akao M
    Circ J; 2018 Apr; 82(5):1327-1335. PubMed ID: 29526914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
    Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
    JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relation of Stroke and Major Bleeding to Creatinine Clearance in Patients With Atrial Fibrillation (from the Fushimi AF Registry).
    Abe M; Ogawa H; Ishii M; Masunaga N; Esato M; Chun YH; Tsuji H; Wada H; Hasegawa K; Lip GY; Akao M
    Am J Cardiol; 2017 Apr; 119(8):1229-1237. PubMed ID: 28219663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Major adverse cardiovascular events and mortality after catheter ablation in Japanese patients with atrial fibrillation: The Fushimi AF Registry.
    Esato M; An Y; Ogawa H; Wada H; Hasegawa K; Tsuji H; Abe M; Akao M
    Heart Vessels; 2021 Aug; 36(8):1219-1227. PubMed ID: 33575844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low Body Weight Is Associated With the Incidence of Stroke in Atrial Fibrillation Patients - Insight From the Fushimi AF Registry.
    Hamatani Y; Ogawa H; Uozumi R; Iguchi M; Yamashita Y; Esato M; Chun YH; Tsuji H; Wada H; Hasegawa K; Abe M; Morita S; Akao M
    Circ J; 2015; 79(5):1009-17. PubMed ID: 25740669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical characteristics of hemodialysis patients with atrial fibrillation: The RAKUEN (Registry of atrial fibrillation in chronic kidney disease under hemodialysis from Niigata) study.
    Mitsuma W; Matsubara T; Hatada K; Imai S; Saito N; Shimada H; Miyazaki S
    J Cardiol; 2016 Aug; 68(2):148-55. PubMed ID: 26527113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
    Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
    Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Importance of non-cardiovascular comorbidities in atrial fibrillation and heart failure with preserved ejection fraction.
    Hamatani Y; Iguchi M; Kato T; Inuzuka Y; Tamaki Y; Ozasa N; Kawaji T; Esato M; Tsuji H; Wada H; Hasegawa K; Abe M; Kimura T; Ono K; Akao M;
    ESC Heart Fail; 2024 Sep; ():. PubMed ID: 39305136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor: The Loire Valley Atrial Fibrillation Project.
    Fauchier L; Lecoq C; Clementy N; Bernard A; Angoulvant D; Ivanes F; Babuty D; Lip GY
    Chest; 2016 Apr; 149(4):960-8. PubMed ID: 26425935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognosis of atrial fibrillation in patients with symptomatic peripheral arterial disease: data from the REduction of Atherothrombosis for Continued Health (REACH) Registry.
    Winkel TA; Hoeks SE; Schouten O; Zeymer U; Limbourg T; Baumgartner I; Bhatt DL; Steg PG; Goto S; Röther J; Cacoub PP; Verhagen HJ; Bax JJ; Poldermans D
    Eur J Vasc Endovasc Surg; 2010 Jul; 40(1):9-16. PubMed ID: 20385507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation.
    Fox KAA; Lucas JE; Pieper KS; Bassand JP; Camm AJ; Fitzmaurice DA; Goldhaber SZ; Goto S; Haas S; Hacke W; Kayani G; Oto A; Mantovani LG; Misselwitz F; Piccini JP; Turpie AGG; Verheugt FWA; Kakkar AK;
    BMJ Open; 2017 Dec; 7(12):e017157. PubMed ID: 29273652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Digoxin treatment is associated with increased total and cardiovascular mortality in anticoagulated patients with atrial fibrillation.
    Pastori D; Farcomeni A; Bucci T; Cangemi R; Ciacci P; Vicario T; Violi F; Pignatelli P
    Int J Cardiol; 2015 Feb; 180():1-5. PubMed ID: 25460369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Residual Risk of Stroke and Death in Anticoagulated Patients According to the Type of Atrial Fibrillation: AMADEUS Trial.
    Senoo K; Lip GY; Lane DA; Büller HR; Kotecha D
    Stroke; 2015 Sep; 46(9):2523-8. PubMed ID: 26205373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Causes of Death in Anticoagulated Patients With Atrial Fibrillation.
    Gómez-Outes A; Lagunar-Ruíz J; Terleira-Fernández AI; Calvo-Rojas G; Suárez-Gea ML; Vargas-Castrillón E
    J Am Coll Cardiol; 2016 Dec; 68(23):2508-2521. PubMed ID: 27931607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term clinical outcomes after major bleeding in patients with atrial fibrillation: the Fushimi AF registry.
    Ogawa H; An Y; Ishigami K; Ikeda S; Doi K; Hamatani Y; Fujino A; Ishii M; Iguchi M; Masunaga N; Esato M; Tsuji H; Wada H; Hasegawa K; Abe M; Lip GYH; Akao M;
    Eur Heart J Qual Care Clin Outcomes; 2021 Mar; 7(2):163-171. PubMed ID: 33107912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
    Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G
    Europace; 2015 Dec; 17(12):1777-86. PubMed ID: 26321406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
    Taillandier S; Olesen JB; Clémenty N; Lagrenade I; Babuty D; Lip GY; Fauchier L
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The CHADS2 and CHA2DS2-VASc scores predict adverse vascular function, ischemic stroke and cardiovascular death in high-risk patients without atrial fibrillation: role of incorporating PR prolongation.
    Chan YH; Yiu KH; Lau KK; Yiu YF; Li SW; Lam TH; Lau CP; Siu CW; Tse HF
    Atherosclerosis; 2014 Dec; 237(2):504-13. PubMed ID: 25463082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Causes of death of patients with non-valvular atrial fibrillation in Asians.
    Krittayaphong R; Boonyapiphat T; Aroonsiriwattana S; Ngamjanyaporn P; Lip GYH
    PLoS One; 2023; 18(3):e0282455. PubMed ID: 36857361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.